Daniel D. Burton - 20 Feb 2025 Form 4 Insider Report for Health Catalyst, Inc. (HCAT)

Role
Chief Executive Officer, Director
Signature
/s/ Benjamin Landry, as Attorney-in-Fact
Issuer symbol
HCAT
Transactions as of
20 Feb 2025
Transactions value $
$0
Form type
4
Filing time
24 Feb 2025, 20:50:07 UTC
Previous filing
03 Dec 2024
Next filing
04 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HCAT Common Stock Award $0 +296,000 +26.24% $0 1,424,047 20 Feb 2025 Direct F1, F2
transaction HCAT Common Stock Award $0 +75,437 +5.3% $0 1,499,484 20 Feb 2025 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents an award of restricted stock units ("RSUs") granted pursuant to the Issuer's 2019 Stock Option and Incentive Plan (the "2019 Plan"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Subject to the terms of the 2019 Plan, 33.33% of the RSUs will vest on December 1, 2025 and, thereafter, the remaining 66.67% of the RSUs will vest in 8 equal quarterly installments.
F2 Excludes 90 shares that were previously reported as held by the Reporting Person due to an inadvertent administrative error.
F3 Represents an award of 75,437 performance-based restricted units ("PRSUs") pursuant to the 2019 Plan, based upon the Issuer's satisfaction of certain performance criteria for the fiscal year ended December 31, 2024. Each PRSU represents a contingent right to receive one share of the Issuer's common stock.